ENDOTHELIAL PROGENITOR CELLS AND RESPONSE TO RANIBIZUMAB IN AGE-RELATED MACULAR DEGENERATION
- 1 September 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Retina
- Vol. 34 (9) , 1802-1810
Abstract
Background: Choroidal neovascularization (CNV) is the main cause of vision loss in age-related macular degeneration (AMD). In experimental CNV, endothelial progenitor cells (EPCs) contribute to the formation of new vessels. The aim of this study was to investigate whether the behavior of EPCs in patients with AMD supports a role for EPCs in human CNV. Methods: The number of circulating EPCs that are considered pure endothelial precursors and EPCs with monocytic characteristics, and the plasma levels of regulatory cytokines were evaluated in 23 patients with AMD with active CNV and 20 matched controls. In the patients, this profile was re-evaluated after ranibizumab. Results: When compared with controls, the patients with AMD showed a lower number of both EPC types (P = 0.03) and higher plasma levels (P = 0.03) of stromal cell–derived factor 1. Three monthly injections of ranibizumab returned to control levels the number of circulating EPCs considered pure endothelial precursors and of stromal cell–derived factor 1, but not of monocytic EPCs. Conclusion: The observations indicate responsiveness of circulating EPCs to the CNV process in AMD. They suggest the hypothesis that increased stromal cell–derived factor 1 production at the CNV site (reflected in higher plasma levels) recruits EPCs from the circulation, and that antivascular endothelial growth factor therapy selectively decreases the recruitment of cells to be incorporated into new vessels.Keywords
This publication has 42 references indexed in Scilit:
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2011
- Ranibizumab Therapy for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2010
- Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trialsBritish Journal of Ophthalmology, 2009
- The SDF‐1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularizationThe FASEB Journal, 2007
- Regulation of endothelial progenitor cell homing after arterial injuryThrombosis and Haemostasis, 2007
- Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Preventing Stem Cell Incorporation into Choroidal Neovascularization by Targeting Homing and Attachment FactorsInvestigative Ophthalmology & Visual Science, 2005
- Choroidal Neovascularization Is Provided by Bone Marrow CellsStem Cells, 2004
- The Role of Adult Bone Marrow-Derived Stem Cells in Choroidal NeovascularizationInvestigative Ophthalmology & Visual Science, 2003
- Growth Features of Choroidal Neovascular Membranes in Age-related Macular DegenerationOphthalmology, 1989